Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · IEX Real-Time Price · USD
79.91
+0.30 (0.38%)
At close: May 8, 2024, 4:00 PM
79.52
-0.39 (-0.49%)
After-hours: May 8, 2024, 7:59 PM EDT
Viking Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
27
Market Cap
8.81B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 0 | - | - |
Dec 31, 2022 | 0 | - | - |
Dec 31, 2021 | 0 | - | - |
Dec 31, 2020 | 0 | - | - |
Dec 31, 2019 | 0 | - | - |
Dec 31, 2018 | 0 | - | - |
Dec 31, 2017 | 0 | - | - |
Dec 31, 2016 | 0 | - | - |
Dec 31, 2015 | 0 | - | - |
Dec 31, 2014 | 0 | - | - |
Dec 31, 2013 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Henry Schein | 12.34B |
Encompass Health | 4.96B |
Bio-Rad Laboratories | 2.67B |
Chemed | 2.29B |
Qiagen | 1.94B |
Stevanato Group | 1.21B |
Penumbra | 1.06B |
Repligen | 607.45M |
VKTX News
- 1 day ago - Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance - CNBC
- 14 days ago - Viking Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update - PRNewsWire
- 17 days ago - Best biotech stocks to buy and hold in 2024: VKTX, SANA, RXRX - Invezz
- 21 days ago - Viking Therapeutics to Report Financial Results for First Quarter 2024 on April 24, 2024 - PRNewsWire
- 22 days ago - Big pharma is looking to fatten profits with buyouts of weight-loss drug companies. Here are 4 candidates. - Market Watch
- 4 weeks ago - This weight-loss ETF has performed well in its first five months. How does it compare with cheaper alternatives? - Market Watch
- 4 weeks ago - Viking Files Registration Statement with SEC for Proposed Initial Public Offering - PRNewsWire
- 5 weeks ago - VKTX, JANX and these biotech stocks are surging in 2024 - Invezz